MIR5582

Across TCGA pan-cancer cohorts, MIR5582 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of MIR5582’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where MIR5582 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR5582 is over-expressed in tumor.

BLCA, ESCA, and LUAD are the cancer types where MIR5582 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR5582 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.461	.002	6	view →
ESCA	All	II,III,IV	+0.679	.017	2	view →
LUAD	All	II,III,IV	+0.352	.016	2	view →
LIHC	All	III,IV	+0.305	.012	2	view →
KICH	All	II,III,IV	+0.256	.005	1	view →
LUSC	All	All	+0.213	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

MIR5582–BLCA

Open the BLCA breakdown →